Dr Charith Adkar

Veronica Silva
March 13, 2018

Dr Charith Adkar is the new chief science officer of medicinal cannabis producer MYM Nutraceuticals Inc. As CSO, he will handle the firm’s scientific, research and technological operations at the Laval and Weedon production facilities. Adkar’s expertise covers plant science, biotechnology, microbiology, molecular host-pathogen interactions and bioinformatics. Adkar obtained his PhD in plant biology and crop production specializing in molecular plant pathology from the Univ of Milano, Italy. He finished his postdoctoral studies at Hirosaki Univ, Japan and Univ de Sherbrooke, Canada. Rob Gietl, CEO of MYM, says Adkar will be instrumental in leading MYM to be a global innovator in the science and technology of medicinal cannabis. MYM is looking to acquire licenses from Health Canada to produce and sell medical cannabis supplements and topical products.


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.